Brussels, 15 October 2008. Eucomed, the voice of medical technology in Europe yesterday agreed its next steps following the joint industry response to the Recast of the Medical Devices Directives in July. Eucomed’s objective is to further engage with the Commission in a constructive dialogue to address the identified concerns with solutions that are supportive of innovation and patient safety.
The next steps are based on the following elements:
Immediately following the MedTech Forum Eucomed will seek meetings with the Commission in order to promote collaborative and fruitful discussions. The ultimate aim is to work together to create a predictable, sustainable and appropriate regulatory environment This environment must support patient access to safe and effective technology whilst stimulating innovation and further enhancing European competitiveness.
Eucomed is the Voice of the medical technology industry in Europe. Eucomed represents directly and indirectly 4500 designers, manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and amelioration of disease and disability. Small and medium sized companies make up more than 80% of this sector. The European medical technology industry invests some EUR 3.8 billion in research and development and employs near to 435,000 highly skilled workers. The mission of Eucomed is to improve patient and clinician access to modern, innovative and reliable medical technology.
Mark Grossien
Director Communications and External Affairs
mark.grossien(at)eucomed(dot)be
+32 (0)2.775.92.24
